Company news
Bioretec Ltd. (OMXHEX:BRETEC) news
Bioretec Ltd. news releases on 6ix. Latest, May 13, 2026: Bioretec clarifies its 2026-2028 financial target regarding the sales margin
Press releases & updates
Bioretec clarifies its 2026-2028 financial target regarding the sales margin
May 13, 2026
New shares of Bioretec Ltd registered with the trade register
April 28, 2026
Final results of Bioretec Ltd's rights issue
April 24, 2026
Inside information: Preliminary result of Bioretec Ltd's rights issue
April 23, 2026
NOTICE OF THE ANNUAL GENERAL MEETING OF BIORETEC LTD
April 20, 2026
Bioretec Ltd publishes an exemption document relating to its rights issue
April 2, 2026
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue
March 27, 2026
The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid
March 26, 2026
Change to the publication date of Business Review: Bioretec publishes January-March 2026 Business Review on 15 May 2026
March 24, 2026
Bioretec Ltd's Financial Statements and Annual Report 2025 published
March 13, 2026
Inside information: Timo Lehtonen takes on a new role at Bioretec as External Executive Advisor and steps down from the management team
March 12, 2026
Notice of the Extraordinary General Meeting of Bioretec Ltd
March 10, 2026
Inside information: Bioretec Ltd's Board of Directors is assessing a potential rights issue in the near future
February 13, 2026
Bioretec Ltd's financial statements bulletin for January-December 2025 will be published on February 13, 2026
February 9, 2026
Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2026
January 30, 2026
CMS Transitional Pass-Through Payment (TPT) description for HCPCS code C1741 has been revised
January 16, 2026
Tuukka Paavola appointed as Chief Financial Officer of Bioretec
January 15, 2026
Bioretec Ltd's schedule for financial reporting and Annual General Meeting in 2026
December 22, 2025
Inside information: Bioretec updates its strategy for 2026-2028 and provides new financial targets
December 16, 2025
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin
December 14, 2025
Change negotiations completed at Bioretec
December 4, 2025
Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design
November 13, 2025
Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness
November 12, 2025
Correction: Bioretec Ltd's Half-year report 2025
October 31, 2025
Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025
October 27, 2025
Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets
October 27, 2025
Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US
October 1, 2025
Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board
September 4, 2025
Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth
September 2, 2025
Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer
August 27, 2025
Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue
August 14, 2025
Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue
June 27, 2025
Final results of Bioretec Ltd's successful rights issue
June 24, 2025
Inside information: Preliminary result of Bioretec Oy's rights issue
June 23, 2025
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue
May 28, 2025
New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register
May 20, 2025
Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec
May 15, 2025
Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products
May 15, 2025
Inside information: Bioretec´s CEO Alan Donze to resign
May 8, 2025